Aveanna Healthcare (NASDAQ:AVAH) Given New $9.00 Price Target at UBS Group

Key Points

• UBS Group has raised Aveanna Healthcare's (NASDAQ:AVAH) price target from $8.00 to $9.00, indicating a potential upside of 3.57% based on the company's previous close.
• The stock has received mixed ratings from analysts, with three rating it a Buy and four assigning a Hold rating, resulting in a current consensus target price of $8.08.
• Aveanna Healthcare's stock is trading at $8.69 with a market capitalization of $1.82 billion, and significant investment activity has been noted from various institutional investors.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) had its price objective increased by UBS Group from $8.00 to $9.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. UBS Group's price target would indicate a potential upside of 3.57% from the company's previous close.

Several other brokerages also recently issued reports on AVAH. Wall Street Zen raised shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Truist Financial lowered their price objective on shares of Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an "underweight" rating to a "neutral" rating and increased their price objective for the stock from $6.00 to $10.00 in a research report on Thursday, September 18th. Jefferies Financial Group raised shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and lowered their price objective for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $8.08.

Aveanna Healthcare Price Performance

AVAH traded up $0.04 during mid-day trading on Monday, hitting $8.69. The stock had a trading volume of 42,913 shares, compared to its average volume of 686,488. The stock's fifty day simple moving average is $7.75 and its 200-day simple moving average is $5.86. The firm has a market capitalization of $1.82 billion, a price-to-earnings ratio of 108.58 and a beta of 2.05. Aveanna Healthcare has a 1-year low of $3.67 and a 1-year high of $9.11.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last posted its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The company had revenue of $450.53 million for the quarter. Aveanna Healthcare had a net margin of 0.85% and a negative return on equity of 54.56%. As a group, research analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Summit Partners L P acquired a new position in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $50,477,000. Teacher Retirement System of Texas raised its stake in shares of Aveanna Healthcare by 50.9% during the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock valued at $270,000 after acquiring an additional 16,835 shares during the last quarter. Diversified Trust Co bought a new position in shares of Aveanna Healthcare during the second quarter valued at $57,000. Rhumbline Advisers raised its stake in shares of Aveanna Healthcare by 4.0% during the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock valued at $410,000 after acquiring an additional 2,918 shares during the last quarter. Finally, Strs Ohio bought a new position in shares of Aveanna Healthcare during the first quarter valued at $218,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.